Taxol hypersensitivity: Rapid retreatment is safe and cost effective

Gynecologic Oncology

Volumn 68, Issue 1, 1998, Pages 25-28

  Olson, John K ^a   Sood, Anil K ^a   Sorosky, Joel I ^a   Anderson, Barrie ^a   Buller, Richard E ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CIMETIDINE; CORTICOSTEROID; DEXAMETHASONE; DIPHENHYDRAMINE; PACLITAXEL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COST CONTROL; DRUG HYPERSENSITIVITY; DRUG INFUSION; DRUG RECHALLENGE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HUMAN; OVARY CANCER; PRIORITY JOURNAL; SYMPTOMATOLOGY;

EID: 0031887779     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4906     Document Type: Article

References (12)

1. Rowinsky E K, Donehower R C. Paclitaxel (Taxol). N Engl J Med. 332:1995;1004-1014.
2. Weiss R B, Bruno S. Hypersensitivity reactions to cancer chemotherapeutic agents. Ann Int Med. 94:1981;66-72.
3. Weiss R, Donehower R C, Wiernik P H. Hypersensitivity reactions from Taxol. J Clin Oncol. 8:1990;1263-1268.
4. Lassus M, Scott D, Legland-Jones B. Allergic reactions associated with Cremophor containing antineoplastics. Am Soc Clin Oncol. 4:1985;268.
5. Greenberger P A, Patterson R, Simon R. Pretreatment of high risk patients requiring radiocontrast media studies. J All Clin Immunol. 67:1981;185-187.
6. Peereboom D M, Donehower R C, Eisenhauer E A. Successful re-treatment with Taxol after major hypersensitivity reactions. J Clin Oncol. 11:1993;885-890.
7. Sood A K, Gelder M S, Huang S W, Morgan L S. Anaphylaxis to carboplatin following multiple previous uncomplicated courses: a case report. Gynecol Oncol. 57:1995;131-132.
8. McGuire W P, Hoskins W J, Brady M F. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med. 334:1996;1-6.
9. O'Dwyer P J, Weiss R B. Hypersensitivity reactions induced by Etoposide. Cancer Treat Rep. 68:1970;959-961.
10. Laskin M S, Lucchesi K J, Morgan M. Paclitaxel rechallenge failure after a major hypersensitivity reaction. J Clin Oncol. 11:1993;2456-2457.
11. Alkan-Onyuksel H, Ramakrishnan S, Chai H-B. A mixed micellar formulation suitable for the parenteral administration of Taxol. Pharm Res. 11:1994;206-212.
12. Priore G D, Smith P, Warshal D P. Case report: paclitaxel-associated hypersensitivity reaction despite high-dose steroids and prolonged infusions. Gynecol Oncol. 56:1995;316-318.